The compliance with PCR assay |
||
---|---|---|
VITEK 2 | 319 (97.85) | 7 (2.15) |
MALDI-TOF MS | 323 (99.08) | 3 (0.92) |
Species | No. (%) n = 326 |
---|---|
307 (94.17) | |
17 (5.21) | |
2 (0.61) |
Isolate No. | VITEK 2 | MALDI-TOF MS | PCR assay based on the |
||||
---|---|---|---|---|---|---|---|
Species identification | Confidence level (probability) | Species identification | Confidence level | Species identification | Product size (bp) | ||
CA67 | clinical strain | low (< 85%) | 99.90% | 569 | |||
CA95 | clinical strain | excellent (96%) | 99.90% | 941 + 569 | |||
CA98 | clinical strain | not identified | – | 99.90% | 569 | ||
CA125 | clinical strain | acceptable (86%) | 99.90% | 569 | |||
CA13 | clinical strain | low (< 85%) | 99.90% | 569 | |||
CA137 | clinical strain | good (91%) | 99.90% | 569 | |||
CA313 | clinical strain | very good |
99.90% | 941 + 569 | |||
reference strain | excellent (98%) | 99.90% | 941 | ||||
reference strain | very good |
99.90% | 569 | ||||
reference strain | low (< 85%) | 99.90% | 700 |
Type of co-occurrence | No. (%) |
---|---|
Single VVC | 197 (60.43) |
VVC + bacteria: | 129 (39.57) |
|
60 (18.40) |
|
41 (12.58) |
|
11 (3.37) |
|
9 (2.76) |
|
3 (0.92) |
|
2 (0.61) |
Methicillin susceptible |
1 (0.31) |
|
1 (0.31) |
|
1 (0.31) |